HomeGYRE • NASDAQ
add
Gyre Therapeutics Inc
Previous close
$7.90
Day range
$7.76 - $8.03
Year range
$6.11 - $14.42
Market cap
725.31M USD
Avg Volume
55.95K
P/E ratio
123.63
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 30.56M | 19.92% |
Operating expense | 22.01M | 8.44% |
Net income | 3.61M | 221.17% |
Net profit margin | 11.81 | 167.80% |
Earnings per share | 0.03 | — |
EBITDA | 7.58M | 61.93% |
Effective tax rate | 22.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.05M | 139.32% |
Total assets | 159.38M | 27.26% |
Total liabilities | 21.97M | -17.92% |
Total equity | 137.42M | — |
Shares outstanding | 90.89M | — |
Price to book | 7.05 | — |
Return on assets | 11.10% | — |
Return on capital | 12.85% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 3.61M | 221.17% |
Cash from operations | 4.68M | 170.92% |
Cash from investing | -1.25M | 47.76% |
Cash from financing | 365.00K | 12.65% |
Net change in cash | 3.91M | 1,793.07% |
Free cash flow | 2.82M | 540.85% |
About
Founded
1997
Headquarters
Website
Employees
579
